Regulation of σ receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple σ binding sites

Yossef Itzhak, Ira Stein

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The σ binding sites are postulated to be involved in various central nervous system (CNS) disorders. The neuroleptic drug, haloperidol, displays high affinity for these receptor sites in the CNS. In the present study the effect of repeated exposure of rats to haloperidol (4 mg/kg/day for 14 days) on σ binding sites labeled with (+)-3-(3-hydroxyphenyl-N-1-(propyl)piperidine ((+)-3-PPP) and 1,3-di-o-tolyl-gun (DTG) was investigated. In addition, the regulatory effect of guanine nucleotides on the binding of these two ligands to brain membranes derived from saline and haloperidol-treated rats was examined. Repeated administration of haloperidol induced down-regulation of (+)[3H]-3-PPP binding sites (75% decrease in the number of binding sites compared to control) which persisted for at least 7 days after termination of the haloperidol-treatment. The down-regulation of (+)-3-PPP binding sites was accompanied by reduced responsiveness to guanine nucleotides (i.e. 5-guanylylimidodiphosphate (Gpp(NH)p) compared to the sensitivity of (+)-3-PPP binding sites to the nucleotides tested in control membranes. However, at the 28th day after termination of the haloperidol-treatment, a complete recovery in the total number of (+)[3H]-3-PPP binding sites was observed, and the sensitivity to guanine nucleotide was regained. These findings suggest a marked plasticity in (+)-3-PPP/σ receptor binding activity. In contrast, [3H]DTG binding sites expressed neither sensitivity to the repeated exposure to haloperidol nor to guanine nucleotides, suggesting a distinction between DTG and (+)-3-PPP binding sites in rat brain.

Original languageEnglish
Pages (from-to)166-172
Number of pages7
JournalBrain Research
Volume566
Issue number1-2
DOIs
StatePublished - Dec 6 1991

Fingerprint

Guanine Nucleotides
Haloperidol
Binding Sites
Firearms
Down-Regulation
Guanylyl Imidodiphosphate
Membranes
Central Nervous System Diseases
Brain
preclamol
Antipsychotic Agents
Nucleotides
Central Nervous System
Ligands

Keywords

  • (+)-3-(3-Hydroxyphenyl)-N-1-(propyl)piperidine
  • 1,3-Di-o-tolyl-guanidine
  • Guanine nucleotide
  • Haloperidol
  • Receptor down-regulation
  • σ Receptor subtype

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Regulation of σ receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol : further evidence for multiple σ binding sites. / Itzhak, Yossef; Stein, Ira.

In: Brain Research, Vol. 566, No. 1-2, 06.12.1991, p. 166-172.

Research output: Contribution to journalArticle

@article{bfc5fa8753ba4ca38b49a101367016a9,
title = "Regulation of σ receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple σ binding sites",
abstract = "The σ binding sites are postulated to be involved in various central nervous system (CNS) disorders. The neuroleptic drug, haloperidol, displays high affinity for these receptor sites in the CNS. In the present study the effect of repeated exposure of rats to haloperidol (4 mg/kg/day for 14 days) on σ binding sites labeled with (+)-3-(3-hydroxyphenyl-N-1-(propyl)piperidine ((+)-3-PPP) and 1,3-di-o-tolyl-gun (DTG) was investigated. In addition, the regulatory effect of guanine nucleotides on the binding of these two ligands to brain membranes derived from saline and haloperidol-treated rats was examined. Repeated administration of haloperidol induced down-regulation of (+)[3H]-3-PPP binding sites (75{\%} decrease in the number of binding sites compared to control) which persisted for at least 7 days after termination of the haloperidol-treatment. The down-regulation of (+)-3-PPP binding sites was accompanied by reduced responsiveness to guanine nucleotides (i.e. 5-guanylylimidodiphosphate (Gpp(NH)p) compared to the sensitivity of (+)-3-PPP binding sites to the nucleotides tested in control membranes. However, at the 28th day after termination of the haloperidol-treatment, a complete recovery in the total number of (+)[3H]-3-PPP binding sites was observed, and the sensitivity to guanine nucleotide was regained. These findings suggest a marked plasticity in (+)-3-PPP/σ receptor binding activity. In contrast, [3H]DTG binding sites expressed neither sensitivity to the repeated exposure to haloperidol nor to guanine nucleotides, suggesting a distinction between DTG and (+)-3-PPP binding sites in rat brain.",
keywords = "(+)-3-(3-Hydroxyphenyl)-N-1-(propyl)piperidine, 1,3-Di-o-tolyl-guanidine, Guanine nucleotide, Haloperidol, Receptor down-regulation, σ Receptor subtype",
author = "Yossef Itzhak and Ira Stein",
year = "1991",
month = "12",
day = "6",
doi = "10.1016/0006-8993(91)91695-W",
language = "English",
volume = "566",
pages = "166--172",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Regulation of σ receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol

T2 - further evidence for multiple σ binding sites

AU - Itzhak, Yossef

AU - Stein, Ira

PY - 1991/12/6

Y1 - 1991/12/6

N2 - The σ binding sites are postulated to be involved in various central nervous system (CNS) disorders. The neuroleptic drug, haloperidol, displays high affinity for these receptor sites in the CNS. In the present study the effect of repeated exposure of rats to haloperidol (4 mg/kg/day for 14 days) on σ binding sites labeled with (+)-3-(3-hydroxyphenyl-N-1-(propyl)piperidine ((+)-3-PPP) and 1,3-di-o-tolyl-gun (DTG) was investigated. In addition, the regulatory effect of guanine nucleotides on the binding of these two ligands to brain membranes derived from saline and haloperidol-treated rats was examined. Repeated administration of haloperidol induced down-regulation of (+)[3H]-3-PPP binding sites (75% decrease in the number of binding sites compared to control) which persisted for at least 7 days after termination of the haloperidol-treatment. The down-regulation of (+)-3-PPP binding sites was accompanied by reduced responsiveness to guanine nucleotides (i.e. 5-guanylylimidodiphosphate (Gpp(NH)p) compared to the sensitivity of (+)-3-PPP binding sites to the nucleotides tested in control membranes. However, at the 28th day after termination of the haloperidol-treatment, a complete recovery in the total number of (+)[3H]-3-PPP binding sites was observed, and the sensitivity to guanine nucleotide was regained. These findings suggest a marked plasticity in (+)-3-PPP/σ receptor binding activity. In contrast, [3H]DTG binding sites expressed neither sensitivity to the repeated exposure to haloperidol nor to guanine nucleotides, suggesting a distinction between DTG and (+)-3-PPP binding sites in rat brain.

AB - The σ binding sites are postulated to be involved in various central nervous system (CNS) disorders. The neuroleptic drug, haloperidol, displays high affinity for these receptor sites in the CNS. In the present study the effect of repeated exposure of rats to haloperidol (4 mg/kg/day for 14 days) on σ binding sites labeled with (+)-3-(3-hydroxyphenyl-N-1-(propyl)piperidine ((+)-3-PPP) and 1,3-di-o-tolyl-gun (DTG) was investigated. In addition, the regulatory effect of guanine nucleotides on the binding of these two ligands to brain membranes derived from saline and haloperidol-treated rats was examined. Repeated administration of haloperidol induced down-regulation of (+)[3H]-3-PPP binding sites (75% decrease in the number of binding sites compared to control) which persisted for at least 7 days after termination of the haloperidol-treatment. The down-regulation of (+)-3-PPP binding sites was accompanied by reduced responsiveness to guanine nucleotides (i.e. 5-guanylylimidodiphosphate (Gpp(NH)p) compared to the sensitivity of (+)-3-PPP binding sites to the nucleotides tested in control membranes. However, at the 28th day after termination of the haloperidol-treatment, a complete recovery in the total number of (+)[3H]-3-PPP binding sites was observed, and the sensitivity to guanine nucleotide was regained. These findings suggest a marked plasticity in (+)-3-PPP/σ receptor binding activity. In contrast, [3H]DTG binding sites expressed neither sensitivity to the repeated exposure to haloperidol nor to guanine nucleotides, suggesting a distinction between DTG and (+)-3-PPP binding sites in rat brain.

KW - (+)-3-(3-Hydroxyphenyl)-N-1-(propyl)piperidine

KW - 1,3-Di-o-tolyl-guanidine

KW - Guanine nucleotide

KW - Haloperidol

KW - Receptor down-regulation

KW - σ Receptor subtype

UR - http://www.scopus.com/inward/record.url?scp=0026043081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026043081&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(91)91695-W

DO - 10.1016/0006-8993(91)91695-W

M3 - Article

C2 - 1667608

AN - SCOPUS:0026043081

VL - 566

SP - 166

EP - 172

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -